Secondary Prevention of Small Subcortical Strokes (SPS3) Trial

Trial Profile

Secondary Prevention of Small Subcortical Strokes (SPS3) Trial

Phase of Trial: Phase III

Latest Information Update: 20 Jul 2017

At a glance

  • Drugs Clopidogrel (Primary) ; Aspirin
  • Indications Embolism and thrombosis; Stroke
  • Focus Therapeutic Use
  • Acronyms SPS3
  • Most Recent Events

    • 20 Jul 2017 Results (n=2916) assessing cognitive function, presented at the Alzheimer's Association International Conference 2017.
    • 17 Feb 2016 Results (Levels of Inflammatory Markers in the Treatment of Stroke (LIMITS) study) published in the Stroke (n = 1244).
    • 13 Jan 2016 Results of post hoc analysis published in the Circulation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top